Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study

Sonja M Bjerk, Jason V Baker, Sean Emery, Jacqueline Neuhaus, Brian Angus, Fred M Gordin, Sarah L Pett, Christoph Stephan, Ken M Kunisaki, INSIGHT SMART Study Group, M. Ristola

Research output: Contribution to journalJournal articleResearchpeer-review

18 Citations (Scopus)

Abstract

Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do not currently exist.
Original languageEnglish
JournalP L o S One
Volume8
Issue number2
Pages (from-to)e56249
ISSN1932-6203
DOIs
Publication statusPublished - 2013

Keywords

  • Adult
  • Anti-HIV Agents
  • Biological Markers
  • C-Reactive Protein
  • Case-Control Studies
  • Female
  • Fibrin Fibrinogen Degradation Products
  • HIV Infections
  • Humans
  • Interleukin-6
  • Lung
  • Male
  • Middle Aged
  • Pneumonia, Bacterial
  • Pulmonary Surfactant-Associated Protein D
  • Risk Factors
  • Uteroglobin

Fingerprint

Dive into the research topics of 'Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study'. Together they form a unique fingerprint.

Cite this